申请人:Boehringer Markus
公开号:US20070112012A1
公开(公告)日:2007-05-17
The invention is concerned with novel carbocyclyl fused cyclic amines of formula (I)
wherein A, X
1
to X
3
, Y
1
to Y
3
, Z, R
1
, R
2
, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
该发明涉及化学式(I)中的新型碳环融合的环胺,其中A、X1至X3、Y1至Y3、Z、R1、R2、m和n的定义如描述和权利要求中所定义,以及其生理学上可接受的盐。这些化合物抑制凝血因子Xa,可以用作药物。